AzTrials
AzTrials

Stress, PsychologicalNCT05372601

Prebiotics and Stress Reduction in Women

A study testing Relax+ and Maltodextrin in people with Stress, Psychological, run by FrieslandCampina at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In modern life, many people state to experience stress. Women compared to men report more and higher levels of stress. Recent research found that supplementation of galactose-oligosaccharides (GOS) resulted in reduced anxiety levels in British female students with higher anxiety scores at baseline in self-reported… Read more about this study

Who is it for?
Ages 25 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Stress, Psychological
What is being tested?
Relax+ and Maltodextrin
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
124 participants
Where
1 siteNetherlands
Study dates
17 Feb 2022to 18 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Apparently healthy women
  • Moderate or high stress level; DASS42 stress sub-score ≥19
  • Age between 25 and 45 years
  • Body mass index (BMI) between 18.5 and 30 kg/m2
  • Access to internet and a smart phone

Who cannot join

  • Any metabolic, gastrointestinal, inflammatory or chronic disease
  • History of gastro-intestinal surgery or having (serious) gastrointestinal discomfort
  • Use of supplement to relief stress during or within 2 weeks prior to the start of the study
  • Use of pre- and/or probiotics during the study (except for the study product) or within 4 weeks prior to the start of the study
  • Use of medication that may influence the study results, such as laxatives
  • Self-reported and/or clinical lactose intolerance
Show all 9Show fewer
  • Self-reported and/or active cow's milk protein allergy
  • Pregnant or lactating (or having the wish to become pregnant during the study period, self-reported)
  • Having used antibiotics in the 6 months prior to the start of the study

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • FrieslandCampina Research and Development

    Wageningen, 6708 WH

Other trials in Netherlands

About this study

Official title: The Effect of Galacto-oligosaccharides (GOS) on Self-perceived Stress in Apparently Healthy But Stressed Dutch Women: Randomized Controlled Study

In modern life, many people state to experience stress. Women compared to men report more and higher levels of stress. Recent research found that supplementation of galactose-oligosaccharides (GOS) resulted in reduced anxiety levels in British female students with higher anxiety scores at baseline in self-reported trait anxiety. Moreover, supplementation of probiotics in germ-free rodents resulted in reduced levels of circulating corticosterone (cortisol in humans). These findings illustrate the potential of prebiotic supplementation, through the microbiota-gut-brain (MGB) axis, to improve mental health and wellbeing.

The present study aims to study the effect of oligosaccharides on self-perceived stress.

Being tested
Relax+, Maltodextrin
Medical subject headings
Stress, Psychological

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Relax+Dietary supplement

    Prebiotics, daily administered

  • MaltodextrinDietary supplement

    Placebo, daily administered

Study groups in NCT05372601
Study groupRoleWhat they receive
Relax+ExperimentalRelax+ consists of a powder containing a blend of two prebiotics.
Receives: Dietary Supplement: Relax+
PlaceboPlacebo comparatorThe placebo contains maltodextrin.
Receives: Dietary Supplement: Maltodextrin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perceived stress

    The difference in absolute stress sub-score after the product intervention between the product groups (using the Depression Anxiety Stress Scale (DASS-42)), in which a lower score corresponds with a lower stress level

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2022
  2. Study start17 Feb 2022
  3. Primary completion18 Jun 2022
  4. Study completion18 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
124 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05372601
Sponsor's protocol ID
Stress Defense
Status last verified
Mar 2024
First submitted
11 Feb 2022
Last updated
4 Mar 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Relax+ and Maltodextrin in people with Stress, Psychological, run by FrieslandCampina at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perceived stress (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Mar 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in